Hormonal Counterregulation during Severe Hypoglycaemia under Everyday Conditions in Patients with Type 1 and Insulin-Treated Type 2 Diabetes Mellitus

Abstract

Aim: To determine the counterregulatory hormonal responses to severe hypoglycaemia (SH) in type 1 versus insulin-treated type 2 diabetic patients under everyday conditions.

Methods: Counterregulatory hormones were determined in 28 consecutive type 1 and thirteen insulin-treated type 2 diabetic patients (age 54 ± 18 vs. 75 ± 13 yrs; diabetes duration 27 ± 16 vs. 21 ± 6 yrs) with SH requiring emergency treatment. Blood samples were taken prior to and after effective treatment of SH. SH was defined as an event with neuroglycopenic presentation requiring external intervention by administration of intravenous glucose or oral carbohydrates. 68 % (19/28) of type 1 diabetic patients but none of those with type 2 diabetes had reduced awareness of hypoglycaemia.

Results: Plasma glucose levels were 30 ± 14 prior to and 179 ± 82 mg/dl after treatment of SH; the time between the two measurements was 54 ± 26 minutes. With the exception of higher levels of human growth hormone in type 1 patients - which were attributed to younger age - the other counterregulatory responses to SH showed no significant differences in type 1 vs. type 2 diabetic patients. In both groups glucagon responses were virtually absent while moderate catecholamine responses could be demonstrated. Treatment with β-blockers did not affect hormonal counterregulation in type 1 diabetic patients.

Conclusions: In patients approaching the insulin-deficient end of the spectrum of type 2 diabetes the hormonal responses to SH are comparable to those in patients with longstanding type 1 diabetes. Thus, in advanced type 2 diabetes the risk of developing SH may be similar to that in individuals with type 1 diabetes.

Key words

Severe hypoglycaemia - hormonal counterregulation - type 1 diabetes - type 2 diabetes

References

• 1 Anderson S, Hogskilde P D, Wetterslev J, Bredgaard M, Moller J T, Dahl J B. Appropriateness of leaving emergency medical service treated hypoglycemic patients at home: a retrospective study.  Acta Anaesth Scand. 2002;  46 464-468
• 2 Bolli G, DeFeo P, Campugnucci P, Cartechini M G, Angeletti G, Santeusanio F, Brunetti P, Gerich J E. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon secretion.  Diabetes. 1983;  32 134-141
• 3 Clarke W L, Cox D J, Gonder-Frederick L A, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM.  Diabetes Care. 1995;  18 517-522
• 4 Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine.  Nephron. 1976;  16 31-41
• 5 Cryer P E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.  N Engl J Med. 1980;  303 436-444
• 6 Cryer P E. Hypoglycemia risk reduction in type 1 diabetes.  Exp Clin Endocrinol Diabetes. 2001;  109 (Suppl 2) S412-423
• 7 Cryer P E. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes.  Diabetologia. 2002;  45 937-948
• 8 Dagogo-Jack S E, Craft S, Cryer P E. Hypoglycemia-associated autonomic failure in insulin dependent diabetes mellitus.  J Clin Invest. 1993;  91 819-828
• 9 DCCT . Hypoglycemia in the diabetes control and complications trial.  Diabetes. 1997;  46 271-286
• 10 Fukuda M, Tanaka A, Tahara Y. Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control.  Diabetes. 1988;  37 81-88
• 11 Gerich J E. Hypoglycaemia and counterregulation in type 2 diabetes.  Lancet. 2000;  356 1946-1947
• 12 Heller S R, Cryer P E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.  Diabetes. 1991;  40 223-226
• 13 Heller S R, Robinson R TCE. Hypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention.  Diab Obes Metabol. 2000;  2 75-82
• 14 Hirsch B R, Shamoon H. Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific.  Diabetes. 1987;  36 20-26
• 15 Holstein A, Plaschke A, Egberts E-H. Incidence and costs of severe hypoglycemia.  Diabetes Care. 2002;  25 2109-2110
• 16 Holstein A, Plaschke A, Egberts E-H. Clinical characterisation of severe hypoglycaemia - a prospective population-based study.  Exp Clin Endocrinol Diabetes. 2003;  111 364-369
• 17 Holstein A, Plaschke A, Vogel M-Y, Egberts E-H. Prehospital management of diabetic emergencies - a population-based intervention study.  Acta Anaesth Scand. 2003 a;  47 610-615
• 18 Holstein A, Plaschke A, Hammer C, Ptak M, Kuhn J, Diekmann J, Kleesiek K, Maurer H H, Egberts E-H. Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy.  Eur J Clin Pharmacol. 2003 b;  59 747-754
• 19 Leese G P, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier B M, Morris A D. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes.  Diabetes Care. 2003;  26 1176-1180
• 20 Levy C J, Kinsley B T, Bjaj M, Simonson D C. Effect of glycemic control on glucose counteregulation during hypoglycemia in NIDDM.  Diabetes Care. 1998;  21 1330-1338
• 21 McAulay V, Deary I J, Frier B M. Symptoms of hypoglycaemia in people with diabetes.  Diabet Med. 2001;  18 690-705
• 22 Meneilly G S, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes.  Diabetes. 1994;  43 403-410
• 23 Segel S A, Paramore D S, Cryer P E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.  Diabetes. 2002;  51 724-733
• 24 Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossettti L. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.  J Clin Invest. 1994;  93 2562-2571
• 25 Socransky S J, Pirrallo R G, Rubin J M. Out-of-hospital treatment of hypoglycemia: refusal of transport and patient outcome.  Acad Emerg Med. 1998;  5 1080-1085
• 26 Spyer G, Hattersley A T, MacDonald I A, Amiel S, MacLeod K M. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes.  Lancet. 2000;  356 1970-1974
• 27 Strachan M W, Abraha H D, Sherwood R A, Lammie G A, Deary I J, Ewing F M, Perros P, Frier B M. Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus.  Diabetes Metab Res Rev. 1999;  15 5-12
• 28 Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries F A. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis; vector analysis, and standard tests of heart rate variation and blood pressure responses.  Diabet Med. 1992;  9 166-175